NYU Langone Health | NYU Langone Receives $8M NIH Grant to Develop State-of-Art Brain Implant to Study Epilepsy

Provided by NYU Langone Health NEW YORK, Feb. 17, 2022 /PRNewswire/ — There are more than 3.4 million adults and children in the United States with active epilepsy, and about one million of those experience seizures that are unable to be controlled by medicine. To further understand this intractable form of epilepsy, NYU Langone Health…

Details

The Observer | Brain Implant Technology Lets Paralysis Patients Move, Touch and Feel With Their Thoughts

Brain Implant Technology Lets Paralysis Patients Move, Touch, and Feel With Their Thoughts “The BCI research community is extremely vibrant. They are looking at everything from [enabling people to] walk again, see again, hear again, and even feel again. Anything you can think of, they are researching it,” said Marcus Gerhardt, CEO of Blackrock Neurotech,…

Details

Press Release | High Performing Algorithm To Translate Paralyzed Patients’ Thoughts Into Real-Time Prosthetic Movements

High Performing Algorithm To Translate Paralyzed Patients’ Thoughts Into Real-Time Prosthetic Movements   Blackrock Neurotech to enhance thought-to-prosthetic movement for paralyzed BCI patients by licensing proprietary algorithm from Columbia University. SALT LAKE CITY, Feb. 8, 2022 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has signed an exclusive license for Columbia University’s neural decoder MINT. The license…

Details

Tech First | Thought to text: brain-computer interface lets you type, move robotic arms with your mind

Thought to text: brain-computer interface lets you type, move robotic arms with your mind   Thinking to type sounds interesting to most of us. Crazy and futuristic, yes, but also freeing and fast. But for those with massive spinal cord injuries or degenerative diseases, brain-computer interface technology is an absolute lifeline. In this TechFirst, we…

Details

Analytics Insight | Exclusive Interview with Marcus Gerhardt, CEO of Blackrock Neurotech

Exclusive Interview with Marcus Gerhardt, CEO of Blackrock Neurotech   With the digital transformation taking over the world, the medical industry is also following in its footsteps. In a small span of time, neurotechnology has advanced a lot and it has been a breakthrough in the health industry. Blackrock Neurotech provides innovative tools and neurotech expertise to…

Details

Medsider | Why Building a Community is Crucial for Medical Device Startups: Interview with Blackrock Neurotech Co-Founder and CEO Marcus Gerhardt

Why Building a Community is Crucial for Medical Device Startups: Interview with Blackrock Neurotech Co-Founder and CEO Marcus Gerhardt   A common thread runs through Marcus Gerhardt’s career: If a company involves technology and disruption, it’s probably calling his name. Marcus co-founded Blackrock Neurotech in 2008 with his long-time friend and business partner, Florian Solzbacher. Blackrock’s MoveAgain brain-computer interface…

Details

Health Professional Radio | Blackrock Neurotech – MoveAgain Brain-Computer Interface System

Blackrock Neurotech – MoveAgain Brain-Computer Interface System   Professor Florian Solzbacher, Co-Founder, Chairman, and President of Blackrock Neurotech discusses the MoveAgain Brain-Computer Interface (BCI) System that the FDA has granted a Breakthrough Device designation. It utilizes an array (electrode) implanted in the brain, which decodes intended movement from neuronal activity in the brain. This game-changing portable BCI…

Details

Neural TNW | BCIs had a big year in the lab. In 2022, they’re coming to the market | The Next Web

BCIs had a big year in the lab. In 2022, they’re coming to the market   Brain-computer interfaces are slowly edging into the mainstream. After a string of scientific breakthroughs, neurotech companies are starting to commercialize their research. Among them is Blackrock Neurotech, which focuses on restoring functions that have been impaired by disabilities or accidents. The company is best-known for…

Details

Medgadget | Thought-to-Text Brain-Computer Interface: Interview with Florian Solzbacher, Chairman of Blackrock Neurotech

Thought-to-Text Brain-Computer Interface: Interview with Florian Solzbacher, Chairman of Blackrock Neurotech   Blackrock Neurotech, a medical technology company based in Salt Lake City, created a suite of brain-computer interface systems with the goal of empowering patients to have increased independence and quality of life. This latest technology aims to restore written communication in patients who…

Details

Press Release | Paralyzed Individuals Will Soon Type With Only Their Thoughts – New BCI Platform To Be Released By Blackrock Neurotech

Groundbreaking Brain Computer Interface Technology Expected to Achieve Partial Restoration of Communication Function in Impaired Patients SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has announced plans to commercialize a BCI platform in 2022, with the aim of restoring communication function in patients impaired by disabilities…

Details